Drug application
CIDOFOVIR (CIDOFOVIR)
Drugs@FDA ANDA 201276 · MYLAN INSTITUTIONAL
Key facts
| Drug name | CIDOFOVIR |
|---|---|
| Active ingredients | CIDOFOVIR |
| Application type | ANDA |
| Application number | 201276 |
| Company | MYLAN INSTITUTIONAL |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | EQ 375MG BASE/5ML (EQ 75MG BASE/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jun 27, 2012 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: